1. Alter P, Herzum M, Soufi M, Schaefer JR, Maisch B (2006) Cardiotoxicity of 5-fluorouracil. Cardiovasc Hematol Agents Med Chem 4: 1–5
2. Dencausse Y, Sturm J, Hartung G, Dietzler P, Edler L, Bambach M, Wojatschek C, Lindemann H, Qeisser W (2001) Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-h infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility. Onkologie 24: 476–480
3. Klautke G, Feyerherd P, Ludwig K, Prall F, Foitzik T, Fietkau R (2005) Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer. Br J Cancer 92: 1215–1220
4. Klautke G, Ludwig K, Klar E, Freund M, Fietkau R (2006) Toxicity and efficacy of four schedules of intensified neoadjuvant chemoradiotherapy with irinotecan and 5-FU or capecitabine in patients with locally advanced rectal cancer. Proc Am Soc Clin Oncol. Abstract 13550
5. Mitchell EP, Anne PR, Fry R, Palazzo J, Pequignot E, Fishel R, Goldstein S, Isenberg G, Edmunston T, Curran W (2005) Improved local control with chemoradiation with CPT-11, 5-Fu in neoadjuvant treatment of locally advanced or recurrent adenocarcinoma of the rectum. ASCO Gastrointestinal Cancers Symposium. Abstract 246